Home/Filings/4/0001437749-22-023714
4//SEC Filing

Runyan John S. 4

Accession 0001437749-22-023714

CIK 0000880242other

Filed

Oct 4, 8:00 PM ET

Accepted

Oct 5, 8:17 PM ET

Size

16.9 KB

Accession

0001437749-22-023714

Insider Transaction Report

Form 4
Period: 2022-10-03
Transactions
  • Award

    Option to Purchase Common Stock

    2022-10-03+69,4442,831,201 total
    Exercise: $0.27From: 2022-10-03Exp: 2032-10-03Common stock (69,444 underlying)
  • Award

    Option to Purchase Common Stock

    2022-10-03+23,7502,854,951 total
    Exercise: $0.27From: 2022-10-03Exp: 2032-10-03Common stock (23,750 underlying)
Footnotes (3)
  • [F1]This Option was issued to Reporting Person as payment for $18,750 in fees due to Reporting Person by Issuer in exchange for services on its board of directors for the most recently completed quarterly period, pursuant to the Issuer's 2018 Equity Incentive Plan.
  • [F2]The total reflects the October 2, 2022 expiration of options to purchase 47,500 shares of Issuer's common stock.
  • [F3]This Option was granted to Reporting Person to replace an option that had been issued approximately 10 years ago to compensate Reporting Person for services to the Issuer and had recently expired unexercised due to a discrepancy between the original exercise price and current Issuer stock price, pursuant to plan adopted by the Issuer's Compensation Committee.

Issuer

BIOLARGO, INC.

CIK 0000880242

Entity typeother

Related Parties

1
  • filerCIK 0001531862

Filing Metadata

Form type
4
Filed
Oct 4, 8:00 PM ET
Accepted
Oct 5, 8:17 PM ET
Size
16.9 KB